(Q44063204)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

C Didelot

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Barberi-Heyob

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J-L Merlin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Cytometry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

6-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

Thymidylate synthase and drug resistance

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Fluorouracil: biochemistry and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Differences in resistance to 5-fluorouracil as a function of cell cycle delay and not apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

The action of 5-fluorouracil on human HT29 colon cancer cells grown in SCID mice: mitosis, apoptosis and cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Relationship of cell cycle parameters to in vitro and in vivo chemosensitivity for a series of Lewis lung carcinoma lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

S-phase fraction and breast cancer--a decade of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Intracellular location of thymidylate synthase and its state of phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Posttranscriptional regulation of thymidylate synthase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Can measurements of potential doubling time (Tpot) be compared between laboratories? A quality control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

DNA-synthesis enzyme activity: a biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Assessment of Human Tumour Proliferation Using Bromodeoxyuridine—Current Status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

A method to measure the duration of DNA synthesis and the potential doubling time from a single sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Combined flow cytometry and immunohistochemistry analyses for the assessment of nasopharyngeal carcinoma cell kinetics by in vivo bromodeoxyuridine infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Prognostic importance of thymidylate synthase expression in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Cell-cycle-directed regulation of thymidylate synthase messenger RNA in human diploid fibroblasts stimulated to proliferate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

The clinical status of Tpot as a predictor? Or why no tempest in the Tpot!

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

DNA denaturation sensitivity may invalidate bromodeoxyuridine--DNA flow cytometric analysis of potential doubling times in colorectal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

21 January 2018

Regulation of G1 phase.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.10087

21 January 2018

Identifiers

DOI

10.1002/CYTO.10087

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12116375%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference